THE EXPANDING GENETIC HORIZONS OF PRIMARY ALDOSTERONISM
|
|
- Hillary Lynch
- 6 years ago
- Views:
Transcription
1 THE EXPANDING GENETIC HORIZONS OF PRIMARY ALDOSTERONISM Silvia Monticone 1, Fabrizio Buffolo 1, Martina Tetti 1, Franco Veglio 1, Barbara Pasini, Paolo Mulatero 1 1 Division of Internal Medicine and Hypertension Unit, Department of Medical Sciences, University of Torino, Via Genova, 1, Torino, Italy. Division of Medical Genetics, Department of Medical Sciences, University of Torino, Italy. Corresponding author: Paolo Mulatero, MD, Division of Internal Medicine and Hypertension, Department of Medical Sciences, University of Torino, Via Genova, 1, Torino, Italy. paolo.mulatero@unito.it Phone: +0 Fax: +01 Short title: Genetics of primary aldosteronism Word count: abstract 1; manuscript (without references and figure captions) (with references and figure captions) Key words: primary aldosteronism, familial hyperaldosteronism, aldosterone producing adenoma, KCNJ, ATP1A1, ATPB, CACNA1D, CACNA1H, CTNNB1, APCC 1
2 Study Country Families (n) Patients (n) Sex (M/F) Hypertension (n/tot available) Spontaneous hypokalemia Low renin / elevated ARR Elevated hybrid steroids Reported symptoms / TOD / CV events / other Before the identification of the CYPB1/CYPB chimeric gene Sutherland 1 (1) CANADA 1 /0 / / / n.a. Headache, LVH, retinopathy, death due to cerebrovscular events in siblings of the index case New 1 () USA 1 1 1/0 1/1 1/1 1/1 n.a. Polyuria, polidipsia, enuresis, headache, LVH, retinopathy. Miura 1 () JAPAN 1 1 0/1 1/1 1/1 1/1 n.a. Headache, retinopathy. Born form consanguineous hypertensive parents Giebink 1 () USA 1 /1 / / / n.a. Headache, polyuria, nicturia, retinal arteriolar spasms, LVH. History of cerebral hemorrhage at young age (maternal grandmother) Grim () USA (Dutch Indonesian origin) 1 /0 / 0/ / n.a. LVH New () USA / / n.a. / n.a. Ganguly () USA 1 1/ / / / n.a. Easy fatiguability, muscle cramps and carpopedal spasms, dizziness, exertional dyspnea, headache. One family member died of cerebral hemorrhage at the age of 1, one of myocardial infarction at the age of Oberfield () USA 1 / / n.a. / n.a. n.a. Lee 1 () MEXICO 1 1 1/0 1/1 1/1 1/1 n.a. n.a. Fallo 1 () ITALY 1 /1 / / / n.a. The father of the index cases died of stroke at the age of 0 Woodland 1 () AUSTRALIA /0 / / / n.a. One patient had strong family history of hypertension; the other was an adopted child
3 Connell 1 (1) UK 1 /0 / 1/ / / n.a. Davis 1 (1) UK 1 /0 / 1/ / / The mother of the index case had a cerebrovascular event at the age of O Mahony 1 (1) IRELAND 1 /0 / / / n.a. Strong family history of premature cardiovascular death Yamakita 1 (1) JAPAN n.a. 1 / /1 /1 1/1 n.a. Retinopathy Total 1 /0 /1 (%) /0 (%) 1/1 (0%) / After the identification of the CYPB1/CYPB chimeric gene Study Country Families (n) Patients (n) Sex (M/F) Hypertension (n/tot available) Spontaneous hypokalemia Low renin / elevated ARR Elevated hybrid steroids Reported symptoms / TOD / CV events / other Rich 1 (1) USA 1 1 / /1 1 * /1 # /1 1/1 Prevalence of iuretic induced hypokalemia %. High prevalence of cerebrovascular events in young age as cause of death Comiter 1 (1) USA 1 1 0/1 1/1 0/1 1/1 1/1 Family history of early onset hypertension and death for cerebrovascular events at young age in / 1 st and nd degree relatives Jamieson 1 (1) UK 1 / 1/1 /1 1/1 n.a. n.a. Pascoe 1 (1) FRANCE 1 / / n.a. n.a. n.a. n.a. Gates 1 (0) USA 0 1/1 /0 /1 n.a. n.a. LVH, retinopathy. Family history of cerebral haemorrhage Hsieh 1 (1) CHINA 1 1 n.a. n.a. n.a. n.a. n.a. n.a.^ Litchfield 1 () USA 1 /0 / n.a. n.a. n.a. 1 cerebrovascular events in 1 patients with proven GRA Stowasser 000 () AUSTRALIA 1/1 n.a. / 1/0 1/1 Family history of stroke in some of the families Gates 001 () UK 1 / / / n.a. n.a. Family history of cerebral haemorrhage at young age Yokota 001 () JAPAN 1 0/ / 0/ / n.a. General fatigue, pregnancy induced hypertension. History of not fatal stroke Ding 00 () CHINA 1 / / / / n.a. Headache, muscle weakness, flaccid paralysis, tatany,
4 nicturia, palpitation, stroke in one patient Mulatero 00 () ITALY 1 1 /1 /1 0/1 1/1 1/1 No history of stroke in the affected family members Fallo 00 () ITALY 1 /1 / 1/ 1/ / LVH Vonend 00 () GERMANY 1 /0 / 0/ / / Microalbuminuria Lee 0 (0) KOREA 1 /1 / 0/ / n.a. Two cerebral aneurysms in the same patient Aglony 0 (1) CHILE ^ ^ / / / / n.a. 1 cerebellar stroke Mulatero 0 () ROMANIA 1 1/1 / 0/ / n.a. Family history of aortic dissection at young age / / / / / 1 cerebral aneurysm, family history of stroke SCOTLAND Kamrath 0 () 1 Carvajal 01 () CHILE 1 /1 1/ 1/ / / Total 0 1/1 1/ /1 (1%) / (0%) / (%) Supplemental table S1. Main clinical and biochemical features of patients affected by Familial Hyperaldosteronism type I before and after the identification of the CYPB1/CYPB chimeric gene. Hypertension was defined according to the 01 ESH guideline ; hypokalemia was defined as serum K + <. mmol/l; low renin was defined as PRA < 1 ng/ml/h (1. pmol/l/min) ; elevated ARR was defined as > 0 ng*dl - 1 /ng*ml -1 *h -1 (0 pmol*l -1 /pmol*l -1 *min -1 ) TOD = target organ damage; CV events = cardiovascular events; LVH = left ventricular hypertropy. * spontaneous hypokalemia was reported at diagnosis of hypertension, but the patient was found to be normokalemic at further evaluations; # one patient had normal PRA (.0 ng/l*s) under treatment with K + sparing diuretic; full text not available in English; ^ compared to the original manuscript, one family and three patients have been omitted since they are included in Carvajal 01 ().
5 Supplemental references Sutherland DJ, Ruse JL & Laidlaw JC. Hypertension, increased aldosterone secretion and low plasma renin activity relieved by dexamethasone. The Canadian Medical Association Journal New MI & Peterson RE. A new form of congenital adrenal hyperplasia. Journal of Clinical Endocrinology and Metabolism (doi:.1/jcem---00). Miura K, Yoshinaga K, Goto K, Katsushima I, Maebashi M, Demura H, Iino M, Demura R & Torikai T. A case of glucocorticoid-responsive hyperaldosteronism. Journal of Clinical Endocrinology and Metabolism 1 -. (doi:.1/jcem--1-). Giebink GS, Gotlin RW, Biglieri EG & Katz FH. A kindred with familial glucocorticoid suppressible aldosteronism. Journal of Clinical Endocrinology and Metabolism (doi:.1/jcem---1). Grim CE & Weinberger MH. Familial, dexamethasone-suppressible, normokalemic hyperaldosteronism. Pediatrics -0.. New MI, Oberfield SE, Levine LS, Dupont B, Pollack M, Gill JR Jr & Bartter FC. Autosomal dominant transmission and absence of HLA linkage in dexamethasone suppressible hyperaldosteronism. Lancet Ganguly A, Grim CE, Bergstein J, Brown RD & Weinberger MH. Genetic and pathophysiologic studies of a new kindred with glucocorticoid-suppressible hyperaldosteronism manifest in three generations. Journal of Clinical Endocrinology and Metabolism 0-. (doi:.1/jcem---0). Oberfield SE, Levine LS, Stoner E, Chow D, Rauh W, Greig F, Lee SM, Lightner E, Witte M & New MI. Adrenal glomerulosa function in patients with dexamethasone-suppressible hyperaldosteronism. Journal of Clinical Endocrinology and Metabolism 1-1. (doi:.1/jcem--1-1)
6 Lee SM, Lightner E, Witte M, Oberfield S, Levine L & New MI. Dexamethasone suppressible hyperaldosteronism in a child with nephrosclerosis. Acta Endocrinologica (Copenh) Fallo F, Sonino N, Armanini D, Luzzi T, Pedini F, Pasini C, Mantero F. A new family with dexamethasone-suppressible hyperaldosteronism: aldosterone unresponsiveness to angiotensin II. Clinical Endocrinology (Oxf) Woodland E, Tunny TJ, Hamlet SM, Gordon RD. Hypertension corrected and aldosterone responsiveness to renin-angiotensin restored by long-term dexamethasone in glucocorticoidsuppressible hyperaldosteronism. Clinical and Experimental Pharmacology and Physiology Connell JM, Kenyon CJ, Corrie JE, Fraser R, Watt R, Lever AF. Dexamethasonesuppressible hyperaldosteronism. Adrenal transition cell hyperplasia? Hypertension Davis JR, Burt D, Corrie JE, Edwards CR, Sheppard MC. Dexamethasone-suppressible hyperaldosteronism: studies on overproduction of 1-hydroxycortisol in three affected family members. Clinical Endocrinology (Oxf) O'Mahony S, Burns A, Murnaghan DJ. Dexamethasone-suppressible hyperaldosteronism: a large new kindred. Journal of Human Hypertension Yamakita N, Yasuda K, Noritake N, Mercado-Asis LB, Murase H, Mune T, Morita H, Miura K. Study on clinical and endocrine characteristics of dexamethasone-suppressible hyperaldosteronism compared with those in primary aldosteronism owing to aldosteroneproducing adenoma. Acta Endocrinologica (Copenhagen) Rich GM1, Ulick S, Cook S, Wang JZ, Lifton RP & Dluhy RG. Glucocorticoid-remediable aldosteronism in a large kindred: clinical spectrum and diagnosis using a characteristic biochemical phenotype. Annals of Internal Medicine
7 Comiter CV, Capelouto CC, Tobin MS, Dluhy RG & Richie JP. Glucocorticoid remediable aldosteronism: a rare hereditary form of adrenocorticotropic hormone regulated mineralocorticoid hypertension. Journal of Urology Jamieson A, Slutsker L, Inglis GC, Fraser R, White PC & Connell JM. Glucocorticoidsuppressible hyperaldosteronism: effects of crossover site and parental origin of chimaeric gene on phenotypic expression. Clinical Science (London) Pascoe L, Jeunemaitre X, Lebrethon MC, Curnow KM, Gomez-Sanchez CE, Gasc JM, Saez JM & Corvol P. Glucocorticoid-suppressible hyperaldosteronism and adrenal tumors occurring in a single French pedigree. The Journal of Clinical Investigation 1 -. (doi:./jci) 0. Gates LJ1, MacConnachie AA, Lifton RP, Haites NE & Benjamin N. Variation of phenotype in patients with glucocorticoid remediable aldosteronism. Journal of Medical Genetics Hsieh CJ1, Wang PW, Liu JC, Tung SC, Chien WY, Lu YC & Kuo MC. Glucocorticoid remediable aldosteronism: a case report. Changgeng Yi Xue Za Zhi Litchfield WR, Anderson BF, Weiss RJ, Lifton RP & Dluhy RG. Intracranial aneurysm and hemorrhagic stroke in glucocorticoid-remediable aldosteronism. Hypertension Stowasser M, Bachmann AW, Huggard PR, Rossetti TR & Gordon RD. Severity of hypertension in familial hyperaldosteronism type I: relationship to gender and degree of biochemical disturbance. Journal of Clinical Endocrinology and Metabolism (doi:.1/jcem...1). Gates LJ, Benjamin N, Haites NE, MacConnachie AA, McLay JS. Is random screening of value in detecting glucocorticoid-remediable aldosteronism within a hypertensive
8 population? Journal of Human Hypertension (doi:./sj.jhh.0). Yokota K, Ogura T, Kishida M, Suzuki J, Otsuka F, Mimura Y, Oishi T, Hirata M, Tobe K & Makino H. Japanese family with glucocorticoid-remediable aldosteronism diagnosed by long-polymerase chain reaction. Hypertension Research Ding W, Liu L, Hu R, Xu M & Chen J. Clinical and gene mutation studies on a Chinese pedigree with glucocorticoid-remediable aldosteronism. Chinese Medical Journal (English) Mulatero P, di Cella SM, Williams TA, Milan A, Mengozzi G, Chiandussi L, Gomez-Sanchez CE & Veglio F. Glucocorticoid remediable aldosteronism: low morbidity and mortality in a four-generation Italian pedigree. Journal of Clinical Endocrinology and Metabolism (doi:.1/jcem...). Fallo F, Pilon C, Williams TA, Sonino N, Morra Di Cella S, Veglio F, De Iasio R, Montanari P & Mulatero P. Coexistence of different phenotypes in a family with glucocorticoid-remediable aldosteronism. Journal of Human Hypertension (doi:./sj.jhh.01). Vonend O, Altenhenne C, Büchner NJ, Dekomien G, Maser-Gluth C, Weiner SM, Sellin L, Hofebauer S, Epplen JT & Rump LC. A German family with glucocorticoid-remediable aldosteronism. Nephrology Dialisis Transplantation (doi:./ndt/gfl0) 0. Lee IS, Kim SY, Jang HW, Kim MK, Lee JH, Lee YH & Jo YS. Genetic analyses of the chimeric CYPB1/CYPB gene in a Korean family with glucocorticoid-remediable aldosteronism. Journal of Korean Medical Sciences (doi:./jkms.0...1) 1. Aglony M, Martínez-Aguayo A, Carvajal CA, Campino C, García H, Bancalari R, Bolte L, Avalos C, Loureiro C, Trejo P, Brinkmann K, Giadrosich V, Mericq V, Rocha A, Avila A,
9 Perez V, Inostroza A & Fardella CE. Frequency of familial hyperaldosteronism type 1 in a hypertensive pediatric population: clinical and biochemical presentation. Hypertension (doi:.1/hypertensionaha.1.). Mulatero P, Tizzani D, Viola A, Bertello C, Monticone S, Mengozzi G, Schiavone D, Williams TA, Einaudi S, La Grotta A, Rabbia F & Veglio F. Prevalence and characteristics of familial hyperaldosteronism: the PATOGEN study (Primary Aldosteronism in Torino - GENetic forms). Hypertension 0-0. (doi:.1/hypertensionaha.1.). Kamrath C, Maser-Gluth C, Haag C & Schulze E. Diagnosis of glucocorticoid-remediable aldosteronism in hypertensive children. Hormon Research in Paediatrics 0 -. (doi:./000). Carvajal CA, Campino C, Martinez-Aguayo A, Tichauer JE, Bancalari R, Valdivia C, Trejo P, Aglony M, Baudrand R, Lagos CF, Mellado C, Garcia H & Fardella CE. A new presentation of the chimeric CYPB1/CYPB gene with low prevalence of primary aldosteronism and atypical gene segregation pattern. Hypertension (doi:.1/hypertensionaha.1.1) Mancia G, Fagard R, Narkiewicz K, Redon J, Zanchetti A, Böhm M, Christiaens T, Cifkova R, De Backer G, Dominiczak A, Galderisi M, Grobbee DE, Jaarsma T, Kirchhof P, Kjeldsen SE, Laurent S, Manolis AJ, Nilsson PM, Ruilope LM, Schmieder RE, Sirnes PA, Sleight P, Viigimaa M, Waeber B, Zannad F, Redon J, Dominiczak A, Narkiewicz K, Nilsson PM, Burnier M, Viigimaa M, Ambrosioni E, Caufield M, Coca A, Olsen MH, Schmieder RE, Tsioufis C, van de Borne P, Zamorano JL, Achenbach S, Baumgartner H, Bax JJ, Bueno H, Dean V, Deaton C, Erol C, Fagard R, Ferrari R, Hasdai D, Hoes AW, Kirchhof P, Knuuti J, Kolh P, Lancellotti P, Linhart A, Nihoyannopoulos P, Piepoli MF, Ponikowski P, Sirnes PA, Tamargo JL, Tendera M, Torbicki A, Wijns W, Windecker S, Clement DL, Coca A,
10 Gillebert TC, Tendera M, Rosei EA, Ambrosioni E, Anker SD, Bauersachs J, Hitij JB, Caulfield M, De Buyzere M, De Geest S, Derumeaux GA, Erdine S, Farsang C, Funck- Brentano C, Gerc V, Germano G, Gielen S, Haller H, Hoes AW, Jordan J, Kahan T, Komajda M, Lovic D, Mahrholdt H, Olsen MH, Ostergren J, Parati G, Perk J, Polonia J, Popescu BA, Reiner Z, Rydén L, Sirenko Y, Stanton A, Struijker-Boudier H, Tsioufis C, van de Borne P, Vlachopoulos C, Volpe M & Wood DA. ESH/ESC guidelines for the management of arterial hypertension: the Task Force for the Management of Arterial Hypertension of the European Society of Hypertension (ESH) and of the European Society of Cardiology (ESC). European Heart Journal (doi:./eurheartj/eht). Funder JW, Carey RM, Fardella C, Gomez-Sanchez CE, Mantero F, Stowasser M, Young WF Jr & Montori VM; Endocrine Society. Case detection, diagnosis, and treatment of patients with primary aldosteronism: an endocrine society clinical practice guideline. Journal of Clinical Endocrinology and Metabolism (doi:.1/jc.00-0) 1
A case report of malignant hypertension in a young woman
Michelli et al. BMC Nephrology (2016) 17:65 DOI 10.1186/s12882-016-0291-x CASE REPORT A case report of malignant hypertension in a young woman Andrea Michelli, Stella Bernardi *, Andrea Grillo, Emiliano
More informationSPRINT: the race for optimal blood pressure control
European Heart Journal (2016) 37, 937 941 doi:10.1093/eurheartj/ehv621 EDITOR S PAGE SPRINT: the race for optimal blood pressure control Thomas F. Lüscher 1 * and Isabella Sudano 2 1 Editorial Office,
More informationCase Report A Case of Glucocorticoid Remediable Aldosteronism and Thoracoabdominal Aneurysms
Case Reports in Endocrinology Volume 2016, Article ID 2017571, 4 pages http://dx.doi.org/10.1155/2016/2017571 Case Report A Case of Glucocorticoid Remediable Aldosteronism and Thoracoabdominal Aneurysms
More informationComparison of Acceptability of Traditional and Novel Blood Pressure Measurement Methods
Brief Communication Comparison of Acceptability of Traditional and Novel Blood Pressure Measurement Methods Annika S. Lindroos, 1,2 Antti M. Jula, 2 Pauli J. Puukka, 2 Ilkka Kantola, 1 Veikko Salomaa,
More informationEndocrine hypertensionmolecules. Marie Freel Caledonian Endocrine Society Meeting 29 th November 2015
Endocrine hypertensionmolecules and genes Marie Freel Caledonian Endocrine Society Meeting 29 th November 2015 Plan Mineralocorticoid hypertension Myths surrounding Primary Aldosteronism (PA) New developments
More informationFamilial hyperaldosteronism
Brazilian Journal of Medical and Biological Research (2000) 33: 1149-1155 Familial hyperaldosteronism ISSN 0100-879X 1149 Familial hyperaldosteronism D.J. Torpy 1, C.A. Stratakis 2 and G.P. Chrousos 3
More informationA German family with glucocorticoid-remediable aldosteronism
Nephrol Dial Transplant (2007) 22: 1123 1130 doi:10.1093/ndt/gfl706 Advance Access publication 3 February 2007 Original Article A German family with glucocorticoid-remediable aldosteronism Oliver Vonend
More informationAn Assessment of the Accuracy of Home Blood Pressure Monitors When Used in Device Owners
Original Article An Assessment of the Accuracy of Home Blood Pressure Monitors When Used in Device Owners Jennifer S. Ringrose, 1 Gina Polley, 1 Donna McLean, 2 4 Ann Thompson, 1,5 Fraulein Morales, 1
More informationGlucocorticoid-Remediable Aldosteronism. atualização. Graham T. McMahon Robert G. Dluhy ABSTRACT RESUMO
atualização Glucocorticoid-Remediable Aldosteronism Graham T. McMahon Robert G. Dluhy ABSTRACT Glucocorticoid-remediable aldosteronism (GRA) is a monogenic form of human hypertension that predisposes to
More informationR J M E Romanian Journal of Morphology & Embryology
Rom J Morphol Embryol 2018, 59(1):323 328 CASE REPORT R J M E Romanian Journal of Morphology & Embryology http://www.rjme.ro/ Morphological and functional renovascular changes as cause of resistant arterial
More informationHypertension is a leading cause of the mortality and
Dietary Sodium Consumption Predicts Future Blood Pressure and Incident Hypertension in the Japanese Normotensive General Population Hiroyuki Takase, MD, PhD; Tomonori Sugiura, MD, PhD; Genjiro Kimura,
More informationPrimary aldosteronism clinical practice guidelines: a re-appraisal The Management of Primary Aldosteronism
Primary aldosteronism clinical practice guidelines: a re-appraisal The Management of Primary Aldosteronism Prof. FRANCO MANTERO Division of Endocrinology University of Padua Italy Case Detection, Diagnosis
More informationRoles of Clinical Criteria, Computed Tomography Scan, and Adrenal Vein Sampling in Differential Diagnosis of Primary Aldosteronism Subtypes
ORIGINAL Endocrine ARTICLE Care Roles of Clinical Criteria, Computed Tomography Scan, and Adrenal Vein Sampling in Differential Diagnosis of Primary Aldosteronism Subtypes Paolo Mulatero, Chiara Bertello,
More informationDietary counselling has no effect on cardiovascular riskfactorsamongchinesegrade1hypertensive patients: a randomized controlled trial
European Heart Journal (2015) 36, 2598 2607 doi:10.1093/eurheartj/ehv329 CLINICAL RESEARCH Disease management Dietary counselling has no effect on cardiovascular riskfactorsamongchinesegrade1hypertensive
More informationDexamethasone-Suppressible Hyperaldosteronism
Dexamethasone-Suppressible Hyperaldosteronism Adrenal Transition Cell Hyperplasia? JOHN M.C. CONNELL, CHRISTOPHER J. KENYON, JOHN E.T. CORRIE, ROBERT FRASER, RUBY WATT, AND ANTHONY F. LEVER SUMMARY Dexamethasone-suppressible
More informationKnowledge and Implementation of the New European Guide in the Management of Arterial Hypertension. The Cigema Survey
Pharmaceuticals 2009, 2, 11-32; doi:10.3390/ph2020011 Article OPEN ACCESS Pharmaceuticals ISSN 1424-8247 www.mdpi.com/journal/pharmaceuticals Knowledge and Implementation of the New European Guide in the
More informationOriginal Article Effect of valsartan on insulin resistance in patients with hypertension: a systematic review and meta-analysis
Int J Clin Exp Med 2016;9(7):14047-14056 www.ijcem.com /ISSN:1940-5901/IJCEM0023467 Original Article Effect of valsartan on insulin resistance in patients with hypertension: a systematic review and meta-analysis
More informationKing s Research Portal
King s Research Portal DOI: 10.1016/j.amjcard.2017.04.052 Document Version Peer reviewed version Link to publication record in King's Research Portal Citation for published version (APA): Delsart, P.,
More informationPrimary aldosteronism (PA) is a common form of endocrine
Drug Effects on Aldosterone/Plasma Renin Activity Ratio in Primary Aldosteronism Paolo Mulatero, Franco Rabbia, Alberto Milan, Cristina Paglieri, Fulvio Morello, Livio Chiandussi, Franco Veglio Abstract
More informationFamilial hyperaldosteronism type I (FH-I; Online Mendelian
Frequency of Familial Hyperaldosteronism Type 1 in a Hypertensive Pediatric Population Clinical and Biochemical Presentation Marlene Aglony, Alejandro Martínez-Aguayo, Cristian A. Carvajal, Carmen Campino,
More informationDetection of Atrial Fibrillation Using a Modified Microlife Blood Pressure Monitor
nature publishing group Detection of Atrial Fibrillation Using a Modified Microlife Blood Pressure Monitor Joseph Wiesel 1, Lorenzo Fitzig 1, Yehuda Herschman 2 and Frank C. Messineo 1 Background Hypertension
More informationOnline Supplement. KCNJ5 Mutations in European Families with Non-Glucocorticoid Remediable Familial Hyperaldosteronism
Online Supplement KCNJ5 Mutations in European Families with Non-Glucocorticoid Remediable Familial Hyperaldosteronism Paolo Mulatero* 1, Philipp Tauber* 2, Maria Christina Zennaro* 3,4,5, Silvia Monticone
More information4/23/2015. Objectives DISCLOSURES
2015 PENS Conference Savannah, GA Novel Cases of Congenital Hyperreninemic Hypaldosteronism Jan M. Foote DISCLOSURES I have no actual or potential conflicts of interest in relation to this presentation.
More informationSpectrum of Hypertension & Hypokalemia
Spectrum of Hypertension & Hypokalemia Farheen K. Dojki, PGY-6 Hypertension Fellow, ASH Hypertension Center Dr. Dojki does not have any relevant financial relationships with any commercial interests. OBJECTIVES:
More informationPrimary Aldosteronism: screening, diagnosis and therapy
Primary Aldosteronism: screening, diagnosis and therapy Jacques W.M. Lenders, internist DEPT. OF INTERNAL MEDICINE, RADBOUD UNIVERSITY NIJMEGEN MEDICAL CENTER, NIJMEGEN,THE NETHERLANDS DEPT. OF INTERNAL
More informationSupplementary appendix
Supplementary appendix This appendix formed part of the original submission and has been peer reviewed. We post it as supplied by the authors. Supplement to: Monticone S, D Ascenzo F, Moretti C, et al.
More informationPrimary Aldosteronism
Primary Aldosteronism Odelia Cooper, MD Assistant Professor of Medicine Division of Endocrinology, Diabetes, and Metabolism Cedars-Sinai Medical Center HYPERTENSION CENTER Barriers to diagnosing primary
More informationPredictors of the Home-Clinic Blood Pressure Difference: A Systematic Review and Meta-Analysis
Original Article Predictors of the Home-Clinic Blood Pressure Difference: A Systematic Review and Meta-Analysis James P. Sheppard, 1 Ben Fletcher, 1 Paramjit Gill, 2 Una Martin, 3 Nia Roberts, 4 and Richard
More information2013 ESH/ESC Guidelines for the management of arterial hypertension
European Heart Journal (2013) 34, 2159 2219 doi:10.1093/eurheartj/eht151 ESH AND ESC GUIDELINES 2013 ESH/ESC Guidelines for the management of arterial hypertension The Task Force for the management of
More informationSample Submission Form Hypertension in childhood and adolescence
Sample Submission Form Hypertension in childhood and adolescence Physician Name: Specialty: Clinic / Practice: Street Address: Postal Code: City: Country: Phone: Fax: Email: Patient Information Surname,
More informationDeclaration of conflict of interest
Declaration of conflict of interest Prevalence and main features of resistant hypertension in Central and Eastern Europe: data from the G. Brambilla 1, G. Seravalle 2, R. Cifkova 3, C. Farsang 4, S. Laurent
More informationPeripheral Arterial Stiffness in Primary Aldosteronism
Physiol. Res. 61: 461-468, 2012 Peripheral Arterial Stiffness in Primary Aldosteronism J. ROSA 1,2, Z. ŠOMLÓOVÁ 1, O. PETRÁK 1, B. ŠTRAUCH 1, T. INDRA 1, M. ŠENITKO 3, T. ZELINKA 1, R. HOLAJ 1, J. WIDIMSKÝ
More informationDivision of Endocrinology, Department of Internal Medicine, Korea University Guro Hospital, Korea University College of Medicine, Seoul, 2
Original Article Obesity and Metabolic Syndrome Diabetes Metab J Published online Sep 28, 2018 https://doi.org/10.4093/dmj.2018.0036 pissn 2233-6079 eissn 2233-6087 DIABETES & METABOLISM JOURNAL Proportion
More informationLong-Term Cardio- and Cerebrovascular Events in Patients With Primary Aldosteronism
ORIGINAL Endocrine ARTICLE Care Long-Term Cardio- and Cerebrovascular Events in atients With rimary Aldosteronism aolo Mulatero,* Silvia Monticone,* Chiara Bertello,* Andrea Viola, Davide Tizzani, Andrea
More informationDECLARATION OF CONFLICT OF INTEREST. None to declare
DECLARATION OF CONFLICT OF INTEREST None to declare Sympathetic nerve traffic, insulin resistance and baroreflex control of circulation in patients with resistant hypertension Gino Seravalle Marco Volpe
More informationBiomedical Research 2018; 29 (1): 1-8
Biomedical Research 2018; 29 (1): 1-8 ISSN 0970-938X www.biomedres.info Evaluation of cardiovascular complexities and quality of life related to health in Chinese patients with thyrotoxic heart disease
More informationTor Biering-Sørensen, MD, PhD; Rasmus Mogelvang, MD, PhD; Peter Schnohr, MD, DMSc; Jan Skov Jensen, MD, PhD, DMSc
Cardiac Time Intervals Measured by Tissue Doppler Imaging M-mode: Association With Hypertension, Left Ventricular Geometry, and Future Ischemic Cardiovascular Diseases Tor Biering-Sørensen, MD, PhD; Rasmus
More informationPrimary aldosteronism (PA) has been recognized as a
Aldosterone, Plasma Renin Activity, and Aldosterone/Renin Ratio in a Normotensive Healthy Pediatric Population Alejandro Martinez-Aguayo, Marlene Aglony, Carmen Campino, Hernan Garcia, Rodrigo Bancalari,
More informationDiagnosis of primary aldosteronism (PA), the most frequent
Effect of Adrenocorticotropic Hormone Stimulation During Adrenal Vein Sampling in Primary Aldosteronism Silvia Monticone, Fumitoshi Satoh, Gilberta Giacchetti, Andrea Viola, Ryo Morimoto, Masataka Kudo,
More informationAn Update on Familial Hyperaldosteronism
Review 941 An Update on Familial Hyperaldosteronism Authors Affiliation H. E. Korah, U. I. Scholl Department of Nephrology, Medical School, Heinrich Heine University, University Hospital Düsseldorf, Düsseldorf,
More informationDiagnosis of primary aldosteronism (PA), the most frequent
Effect of Adrenocorticotropic Hormone Stimulation During Adrenal Vein Sampling in Primary Aldosteronism Silvia Monticone, Fumitoshi Satoh, Gilberta Giacchetti, Andrea Viola, Ryo Morimoto, Masataka Kudo,
More informationStress-induced Aldosterone Hyper-Secretion in a Substantial Subset of Patients With Essential Hypertension
ORIGINAL ARTICLE Stress-induced Aldosterone Hyper-Secretion in a Substantial Subset of Patients With Essential Hypertension Athina Markou, Amalia Sertedaki,* Gregory Kaltsas,* Ioannis I. Androulakis, Chrisanthi
More informationBeta Blockers Should Not be Used as First Line Antihypertensive Agent
Debate Beta Blockers Should Not be Used as First Line Antihypertensive Agent M. K. Sharma, MD, DNB, S. C. Manchanda MD, DM, New Delhi, India Introduction Hypertension is an important public health problem
More informationPrimary aldosteronism (PA) is currently believed to be
Aldosterone Impact of Different Diagnostic Criteria During Adrenal Vein Sampling on Reproducibility of Subtype Diagnosis in Patients With Primary Aldosteronism Paolo Mulatero, Chiara Bertello, Norlela
More informationIn 2003, the Seventh Report of the Joint
H Y P E R T E N S I O N A N D D I A B E T E S D E B A T E S Treatment of Prehypertension in Diabetes and Metabolic Syndrome What are the pros? JULIAN SEGURA, MD LUIS M. RUILOPE, MD In 2003, the Seventh
More informationOriginal Article. Roberto FOGARI 1), Paola PRETI 1), Annalisa ZOPPI 1), Andrea RINALDI 1), Elena FOGARI 1), and Amedeo MUGELLINI 1) Introduction
111 Original Article Hypertens Res Vol.30 (2007) No.2 p.111-117 Prevalence of Primary Aldosteronism among Unselected Hypertensive Patients: A Prospective Study Based on the Use of an Aldosterone/Renin
More informationJournal of Human Kinetics volume 43/2014, DOI: /hukin Physical Activity, Sport & Health
Journal of Human Kinetics volume 43/2014, 49-56 DOI: 10.2478/hukin-2014-0089 49 Physical Activity, Sport & Health Can a Single Session of a Community-Based Group Exercise Program Combining Step Aerobics
More informationPhysical Training, Hemodynamic Parameters and Arterial Stiffness: Friends or Foes of the Hypertensive Patient?
Physical Training, Hemodynamic Parameters and Arterial Stiffness: Friends or Foes of the Hypertensive Patient? STELA IURCIUC 1, CLAUDIU AVRAM 2, VLADIANA TURI 1, ANDA MILITARU 1, ADINA AVRAM 1, ANCA MARIA
More informationEuropean Summer School
European Summer School Ønsker om deltagelse i nedenstående summerschool bedes fremsendt til undertegnede senest d.1/4 2008. Ansøgning på max 1 side, samt CV på max 1 side. Bestyrelsen vil herefter indstille
More informationUpon completion, participants should be able to:
Learning Objectives Upon completion, participants should be able to: Describe the causes of secondary hypertension and the prevalence of primary aldosteronism Discuss the diagnostic approach to primary
More information2013 ESH/ESC Guidelines for the management of arterial hypertension
European Heart Journal doi:10.1093/eurheartj/eht151 ESH AND ESC GUIDELINES 2013 ESH/ESC Guidelines for the management of arterial hypertension The Task Force for the management of arterial hypertension
More informationDiagnostic Role of Captopril Challenge Test in Korean Subjects with High Aldosterone-to-Renin Ratios
Original Article Endocrinol Metab 2016;31:277-283 http://dx.doi.org/10.3803/enm.2016.31.2.277 pissn 2093-596X eissn 2093-5978 Diagnostic Role of Captopril Challenge Test in Korean Subjects with High Aldosterone-to-Renin
More informationENDOCRINE FORMS OF HYPERTENSION. Michael Stowasser
ENDOCRINE FORMS OF HYPERTENSION Michael Stowasser Hypertension Unit, University Department of Medicine, Princess Alexandra Hospital, Brisbane 4102, Australia. ENDOCRINE FORMS OF HYPERTENSION Mineralocorticoid
More information2007 Guidelines for the Management of Arterial Hypertension
Guidelines 1105 Guidelines 2007 Guidelines for the Management of Arterial Hypertension The Task Force for the Management of Arterial Hypertension of the European Society of Hypertension (ESH) and of the
More informationRecent studies have demonstrated that primary aldosteronism
Primary Aldosteronism and Hypertensive Disease Lorena Mosso, Cristian Carvajal, Alexis González, Adolfo Barraza, Fernando Avila, Joaquín Montero, Alvaro Huete, Alessandra Gederlini, Carlos E. Fardella
More informationANGIOTENSIN RECEPTOR BLOCKERS ARE FIRST LINE TREATMENT : PRO
ANGIOTENSIN RECEPTOR BLOCKERS ARE FIRST LINE TREATMENT : PRO Prof Xavier Girerd M.D., Ph.D., F.E.S.C. Endocrinology Department Cardiovascular Prevention Unit Groupe Hospitalier Pitié-Salpêtrière Faculté
More informationSCIENTIFIC OPINION. Scientific Opinion of the Panel on Dietetic Products, Nutrition and Allergies. (Question No EFSA-Q )
The EFSA Journal (2008) 824, 1-12 SCIENTIFIC OPINION Evolus and reduce arterial stiffness Scientific substantiation of a health claim related to Lactobacillus helveticus fermented Evolus low-fat milk products
More information2007 Guidelines for the Management of Arterial Hypertension
European Heart Journal doi:10.1093/eurheartj/ehm236 2007 Guidelines for the Management of Arterial Hypertension The Task Force for the Management of Arterial Hypertension of the European Society of Hypertension
More informationProposal form for the evaluation of a genetic test for NHS Service Gene Dossier
Proposal form for the evaluation of a genetic test for NHS Service Gene Dossier Test Disease Population Triad Disease name and description (please provide any alternative names you wish listed) Glucocorticoid-remediable
More informationΑΡΥΙΚΗ ΠΡΟΔΓΓΙΗ ΤΠΔΡΣΑΙΚΟΤ ΑΘΔΝΟΤ. Μ.Β.Παπαβαζιλείοσ Καρδιολόγος FESC - Γιεσθύνηρια ιζμανόγλειον ΓΝΑ Clinical Hypertension Specialist ESH
ΑΡΥΙΚΗ ΠΡΟΔΓΓΙΗ ΤΠΔΡΣΑΙΚΟΤ ΑΘΔΝΟΤ Μ.Β.Παπαβαζιλείοσ Καρδιολόγος FESC - Γιεσθύνηρια ιζμανόγλειον ΓΝΑ Clinical Hypertension Specialist ESH Hypertension Co-Morbidities HTN Commonly Clusters with Other Risk
More informationSystemic Hypertension Dr ahmed almutairi Assistant professor Internal medicine dept
Systemic Hypertension Dr ahmed almutairi Assistant professor Internal medicine dept Continents 1- introduction 2- classification/definition 3- classification/etiology 4-etiology in both categories 5- complications
More informationAbout 20% of the Canadian population
Mineralocorticoid Hypertension: Common and Treatable Hypertension is the most common chronic disease treated by the primary-care physician. It is now evident that mineralocorticoid hypertension, which
More informationMendelian Hypertension: Clinical Implications
Mendelian Hypertension: Clinical Implications Anna Dominiczak MD Regius Professor of Medicine Valencia, ICHCA, 2018 Monogenic Hypertension & Hypotension Gitelman Syndrome Gordon Syndrome Modified from
More informationEndocrine Hypertension
Endocrine Hypertension 1 No Disclosures Endocrine Hypertension Objectives: 1. Understand Endocrine disorders causing hypertension 2. Understand clinical presentation of Pheochromocytoma and Hyperaldosteronism
More informationSecondary hypertension How to approach?
Secondary hypertension How to approach? Tomáš Seeman Department of Pediatrics and Transplantation Center, University Hospital Motol, 2 nd Faculty of Medicine, Charles University Prague, Czech Republic
More informationSeventeen Alpha-hydroxylase Deficiency
17 -hydroxylase deficiency CASE REPORT Seventeen Alpha-hydroxylase Deficiency Siew-Lee Wong, 1,2 San-Ging Shu, 1,3 * Chi-Ren Tsai 1 Seventeen -hydroxylase deficiency (17OHD) is a rare form of congenital
More informationConfirmatory testing in normokalaemic primary aldosteronism: the value of the saline infusion test and urinary aldosterone metabolites
European Journal of Endocrinology (6) 154 865 873 ISSN 84-4643 CLINICAL STUDY Confirmatory testing in normokalaemic primary aldosteronism: the value of the saline infusion test and urinary aldosterone
More informationHow to Recognize Adrenal Disease
How to Recognize Adrenal Disease CME Away India & Sri Lanka March 23 - April 7, 2018 Richard A. Bebb MD, ABIM, FRCPC Consultant Endocrinologist Medical Subspecialty Institute Cleveland Clinic Abu Dhabi
More informationEndocrine. Endocrine as it relates to the kidney. Sarah Elfering, MD University of Minnesota
Endocrine Sarah Elfering, MD University of Minnesota Endocrine as it relates to the kidney Parathyroid gland Vitamin D Endocrine causes of HTN Adrenal adenoma PTH Bone Kidney Intestine 1, 25 OH Vitamin
More informationYear 2004 Paper two: Questions supplied by Megan 1
Year 2004 Paper two: Questions supplied by Megan 1 QUESTION 96 A 32yo woman if found to have high blood pressure (180/105mmHg) at an insurance medical examination. She is asymptomatic. Clinical examination
More informationHome sphygmomanometers can help in the control of blood pressure: a nationwide field survey
Hypertension Research (2018) 41:460 468 https://doi.org/10.1038/s41440-018-0030-8 ARTICLE Home sphygmomanometers can help in the control of blood pressure: a nationwide field survey Tekin Akpolat 1 Mustafa
More informationPrognosis of primary aldosteronism in Japan: results from a nationwide epidemiological study
Endocrine Journal 2013 Or i g i n a l Advance Publication doi: 10.1507/endocrj. EJ13-0353 Prognosis of primary aldosteronism in Japan: results from a nationwide epidemiological study Yoshihiro Miyake 1),
More informationChanges in the clinical manifestations of primary aldosteronism
ORIGINAL ARTICLE Korean J Intern Med 2014;29:217-225 Changes in the clinical manifestations of primary aldosteronism Sun Hwa Kim, Jae Hee Ahn, Ho Cheol Hong, Hae Yoon Choi, Yoon Jung Kim, Nam Hoon Kim,
More informationThe Effects of BATHE Interview Technique on Obese Patient
IOSR Journal of Dental and Medical Sciences (IOSR-JDMS) e-issn: 2279-0853, p-issn: 2279-0861.Volume 16, Issue 12 Ver. VII (Dec. 2017), PP 76-82 www.iosrjournals.org The Effects of Interview Technique on
More informationDiagnostic Accuracy of Adrenal Venous Sampling in Comparison with Other Parameters in Primary Aldosteronism
Endocrine Journal 2008, 55 (5), 839 846 Diagnostic Accuracy of Adrenal Venous Sampling in Comparison with Other Parameters in Primary Aldosteronism ISAO MINAMI, TAKANOBU YOSHIMOTO, YUKI HIRONO, HAJIME
More informationWe are IntechOpen, the world s leading publisher of Open Access books Built by scientists, for scientists. International authors and editors
We are IntechOpen, the world s leading publisher of Open Access books Built by scientists, for scientists 4,000 116,000 120M Open access books available International authors and editors Downloads Our
More informationMineralocorticoid hypertension is a potentially reversible
Mineralocorticoid Hypertension and Hypokalemia Neenoo Khosla and Donn Hogan Mineralocorticoid hypertension is hypertension associated with the presence of hypokalemia, metabolic alkalosis, and suppression
More informationWorking Group on Blood Pressure and Heart Rate Variability European Society of Hypertension
Thursday, June 12 Monza (Mi) University of Milano-Bicocca Building U-8 Auditorium Milan (Italy) Working Group on Blood Pressure and Heart Rate Variability European Society of Hypertension Arterial baroreflex
More informationAssociation between the CYP11B2 gene 344T>C polymorphism and coronary artery disease: a meta-analysis
Association between the CYP11B2 gene 344T>C polymorphism and coronary artery disease: a meta-analysis Y. Liu, H.L. Liu, W. Han, S.J. Yu and J. Zhang Department of Cardiology, The General Hospital of the
More informationThe 2012 European Guidelines on Cardiovascular Disease Prevention in Clinical Practice
The 2012 European Guidelines on Cardiovascular Disease Prevention in Clinical Practice Introduction «meet the Taskforce» Disclosure: no conflicts of interest On behalf of : The 5th Joint European Societies
More informationA Rare Case of Subclinical Primary Aldosteronism and Subclinical Cushing s Syndrome without Cardiovascular Complications
Tokai J Exp Clin Med., Vol. 41, No. 1, pp. 35-41, 216 A Rare Case of Subclinical Primary Aldosteronism and Subclinical Cushing s Syndrome without Cardiovascular Complications Natsumi KITAJIMA *1, Toshiro
More informationPrimary Aldosteronism & Implications for Primary Hypertension
& Implications for Primary Hypertension Richard J. Auchus, MD, PhD, FACE Professor and Fellowship Program Director Depts of Internal Medicine/MEND & Pharmacology University of Michigan Disclosures Contracted
More informationClarification of hypertension Diagnosis of primary hyperaldosteronism
Nr. 1/2010 Clarification of hypertension Diagnosis of primary hyperaldosteronism Marc Beineke The significance of the /renin ratio (ARR) in the diagnosis of normoalaemic and hypokalaemic primary hyperaldosteronism,
More informationFunctional vascular disorders
Functional vascular disorders Raynaud s phenomenon Raynaud s phenomenon Refers to Intermittent,bilateral attacks of ischemia of the fingers or toes, and sometimes ears or nose. It clinically manifests
More informationNutrition Research and Practice 2016;10(3): ; doi: /nrp ; pissn eissn
Nutrition Research and Practice 2016;10(3):288-293 c2016 The Korean Nutrition Society and the Korean Society of Community Nutrition http://e-nrp.org Elevation of heart-femoral pulse wave velocity by short-term
More informationImprove the Hypertension Management
Improve the Hypertension Management Ask for LIAISON Aldosterone and Direct Renin Assays FOR OUTSIDE THE US ONLY Improve the Hypertension Management DiaSorin The Solution Hypertension worldwide estimation
More informationCase Based Urology Learning Program
Case Based Urology Learning Program Resident s Corner: UROLOGY Case Number 4 CBULP 2010 004 Case Based Urology Learning Program Editor: Associate Editors: Manager: Case Contributors: Steven C. Campbell,
More informationRegular physical exercise reduces blood pressure and is
Exercise in Resistant Hypertension Aerobic Exercise Reduces Blood Pressure in Resistant Hypertension Fernando Dimeo, Nikolaos Pagonas, Felix Seibert, Robert Arndt, Walter Zidek, Timm H. Westhoff Abstract
More informationAcknowledgements J Yang is supported by a post-doctoral fellowship from the Endocrine Society of Australia.
08/05/2017 A practical approach to diagnosing endocrine hypertension Jun Yang, Jimmy Shen and Peter J. Fuller Centre for Endocrinology and Metabolism, Hudson Institute of Medical Research and Department
More informationFirst described by Conn in 1955, primary aldosteronism is. Clinicopathologic Correlates of Primary Aldosteronism
Clinicopathologic Correlates of Primary Aldosteronism Primary aldosteronism is the most common cause of secondary hypertension, incurring significant cardiovascular morbidity and mortality. Our understanding
More informationResistant hypertension is defined as blood. Primary Hyperaldosteronism Decoded: A Case of Curable Resistant Hypertension.
Case Review Primary Hyperaldosteronism Decoded: A Case of Curable Resistant Hypertension Timothy R. Larsen, DO, Wadie David, Susan Steigerwalt, MD, Shukri David, MD Department of Internal Medicine, Section
More informationAmong patients with diabetes mellitus, elevated blood. Hypertension
Hypertension Effects of Visit-to-Visit Variability in Systolic Blood Pressure on Macrovascular and Microvascular Complications in Patients With Type 2 Diabetes Mellitus The ADVANCE Trial Jun Hata, MD,
More informationThe management of hypertension
The management of hypertension Aoife Morris, RGN, BSc HDip Cardiovascular Care, Alma Murphy, RGN, BSc HDip Cardiovascular Care, Galway Clinic, Galway and Dr John Clarke, Consultant Cardiologist, Eagle
More informationTRANSITIONING FROM A PEDIATRIC TO AN ADULT ENDOCRINOLOGIST CARLOS A. LEYVA JORDÁN, M.D. PEDIATRIC ENDOCRINOLOGIST
TRANSITIONING FROM A PEDIATRIC TO AN ADULT ENDOCRINOLOGIST CARLOS A. LEYVA JORDÁN, M.D. PEDIATRIC ENDOCRINOLOGIST DISCLOSURE No potential conflict of interest OBJECTIVES Review timing considerations for
More informationValidation of the SEJOY BP-1307 upper arm blood pressure monitor for home. blood pressure monitoring according to the European Society of Hypertension
Validation of the SEJOY BP-1307 upper arm blood pressure monitor for home blood pressure monitoring according to the European Society of Hypertension International Protocol revision 2010 Short title: Validation
More informationAN INDIVIDUALIZED APPROACH TO THE EVALUATION AND MANAGEMENT OF PRIMARY ALDOSTERONISM
Review Article AN INDIVIDUALIZED APPROACH TO THE EVALUATION AND MANAGEMENT OF PRIMARY ALDOSTERONISM Anand Vaidya, MD, MMSc 1 ; Carl D. Malchoff, MD, PhD 2 ; Richard J. Auchus, MD, PhD 3 ; on behalf of
More informationAzienda Ospedaliero-Universitaria, Ospedali Riuniti Umberto I-GM Lancisi-G Salesi, Università
Page 1 of 23 Accepted Preprint first posted on 8 January 2009 as Manuscript EJE-08-0902 SMALL TUMOR SIZE AS FAVOURABLE PROGNOSTIC FACTOR AFTER ADRENALECTOMY IN CONN S ADENOMA 1 Gilberta Giacchetti, 1 Vanessa
More information